Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s): LBLTF

Healthcare Biotechnology

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.

TSXV:LBL.H - Post by User

Lattice Biologics Ltd

Bullboard Posts

Post by AndrewKenon Jan 30, 2017 2:01pm

108 Views

Post# 25773432

LBL COMPLETES $800K PRIVATE PLACEMENT ANNOUNCED ON

2017-01-19.

https://www.stockwatch.com/News/Item.aspx?bid=Z-C%3aLBL-2439788&symbol=LBL&region=C

Lattice Biologics 4,524,260-share private placement

2017-01-27 19:07 ET - Private Placement

The TSX Venture Exchange has accepted for filing documentation with respect to a non-brokered private placement announced Sept. 13, 2016, and Oct. 25, 2016.

Number of shares: 4,524,260 shares

Purchase price: 20 cents per share

Warrants: 2,262,130 share purchase warrants to purchase 2,262,130 shares

Warrant exercise price: 26.5 cents for a three-year period

Number of placees: six placees

Bullboard Posts

High-grade gold potential in the world’s best mining jurisdiction